DOSE MODIFICATION FOR CHINESE PATIENTS ON NIRAPARIB MAINTENANCE TREATMENT FOR PLATINUM-SENSITIVE RECURRENT OVARIAN CANCER: A POST HOC ANALYSIS

被引：0
|
作者：
Liu, Z. [1 ]
Wu, X. [2 ]
Zhu, J. [3 ]
Yin, R. [4 ,5 ]
Yang, J. [6 ]
Liu, J. [7 ]
Wang, J. [8 ]
Wu, L. [9 ]
Tan, T. [10 ]
Dong, J. [10 ]
机构：
[1] First Hosp Jilin Univ, Dept Oncol, Changchun, Peoples R China
[2] Fudan Univ, Shanghai Canc Ctr, Dept Gynecol Oncol, Shanghai, Peoples R China
[3] Univ Chinese Acad Sci, Zhejiang Canc Hosp, Canc Hosp, Dept Gynecol Oncol, Hangzhou, Peoples R China
[4] Sichuan Univ, West China Univ Hosp 2, Dept Obstet & Gynecol, Chengdu, Peoples R China
[5] Sichuan Univ, West China Univ Hosp 2, Key Lab Birth Defects & Related Dis Women & Child, Minist Educ, Chengdu, Peoples R China
[6] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Gynecol Oncol, Beijing, Peoples R China
[7] Sun Yat Sen Univ, Canc Ctr, Dept Gynecol Oncol, Guangzhou, Peoples R China
[8] Cent South Univ, Hunan Canc Hosp, Affiliated Canc Hosp, Xiangya Sch Med,Dept Gynecol Oncol, Changsha, Peoples R China
[9] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Canc Hosp, Dept Gynecol Oncol, Beijing, Peoples R China
[10] Zai Lab Shanghai Co Ltd, RandD Dept, Shanghai, Peoples R China
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2021年 / 31卷
关键词：
D O I：
10.1136/ijgc-2021-ESGO.333
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
29
引用
收藏
页码：A193 / A194
页数：3
相关论文
共 50 条
  • [31] PARP inhibitor maintenance therapy for patients with platinum-sensitive recurrent ovarian cancer: A cost-effectiveness analysis
    Smith, Haller J.
    Haygood, Christen L. Walters
    Arend, Rebecca C.
    Leath, Charles A., III
    Straughn, Michael, Jr.
    GYNECOLOGIC ONCOLOGY, 2015, 139 (01) : 59 - 62
  • [32] ENGOT-OV16/NOVA: A MAINTENANCE STUDY WITH NIRAPARIB VERSUS PLACEBO IN PATIENTS WITH PLATINUM-SENSITIVE OVARIAN CANCER
    Matulonis, U.
    Herrstedt, J.
    Oza, A.
    Mahner, S.
    Redondo, A.
    Fabbro, M.
    Ledermann, J.
    Lorusso, D.
    Vergote, I.
    Rosengarten, O.
    Reinthaller, A.
    Madry, R.
    Monk, B. J.
    Dorum, A.
    Tinker, A. V.
    DuBois, A.
    Gonzalez Martin, A.
    Follana, P.
    Berek, J. S.
    Gilbert, L.
    Benigno, B.
    Rosenberg, P.
    Rimel, B. J.
    Buscema, J.
    Balser, J.
    Agarwal, S.
    Mirza, M. R.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 19 - 20
  • [33] Effect of niraparib on cardiac repolarization in patients with platinum-sensitive, recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer
    Moore, Kathleen
    Chan, John K.
    Secord, Angeles Alvarez
    Patel, Manish R.
    Callahan, Timothy
    Guo, Wei
    Zhang, Zhi-Yi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 83 (04) : 717 - 726
  • [34] Effect of niraparib on cardiac repolarization in patients with platinum-sensitive, recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer
    Kathleen Moore
    John K. Chan
    Angeles Alvarez Secord
    Manish R. Patel
    Timothy Callahan
    Wei Guo
    Zhi-Yi Zhang
    Cancer Chemotherapy and Pharmacology, 2019, 83 : 717 - 726
  • [35] Efficacy of niraparib maintenance therapy in Chinese women with platinum-sensitive recurrent ovarian cancer with and without secondary cytoreductive surgery: Results from the NORA trial.
    Wu, Lingying
    Wu, Xiaohua
    Zhu, Jianqing
    Yin, Rutie
    Yang, Jiaxin
    Liu, Jihong
    Wang, Jing
    Liu, Ziling
    Gao, Yunong
    Wang, Danbo
    Lou, Ge
    Yang, Hongying
    Zhou, Qi
    Kong, Beihua
    Huang, Yi
    Chen, Lipai
    Li, Guiling
    An, Ruifang
    Tan, Tao
    Dong, Juan
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [36] Efficacy and safety of niraparib in platinum-sensitive recurrent ovarian cancer: retrospective observational study in a tertiary hospital
    Prado-Mel, Elena
    Suarez-Casillas, Paloma
    Rodriguez-de Francisco, Lupe
    Estevez-Garcia, Purificacion
    Jimenez-Galan, Rocio
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024,
  • [37] Novel treatment options in platinum-sensitive recurrent ovarian cancer: A review
    Mullen, Mary M.
    Kuroki, Lindsay M.
    Thaker, Premal H.
    GYNECOLOGIC ONCOLOGY, 2019, 152 (02) : 416 - 425
  • [38] Combination carboplatin and pemetrexed for the treatment of platinum-sensitive recurrent ovarian cancer
    Horowitz, N. S.
    Penson, R. T.
    Campos, S. M.
    Lee, J.
    Kendall, D. L.
    Krasner, C. N.
    Berlin, S. T.
    Roche, M.
    Duska, L. R.
    Matulonis, U. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [39] Individualized Starting Dose of Niraparib in Chinese Patients With Platinum-Sensitive Recurrent Ovarian Cancer: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial (NORA)
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (11) : 10 - 12
  • [40] Secondary Cytoreductive Surgery in Patients with Platinum-Sensitive Recurrent Ovarian Cancer
    Pierluigi Benedetti Panici
    Antonio De Vivo
    Filippo Bellati
    Natalina Manci
    Giorgia Perniola
    Stefano Basile
    Ludovico Muzii
    Roberto Angioli
    Annals of Surgical Oncology, 2007, 14 : 1136 - 1142
12345